Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs

Patent Law

: Patent Docs

Amgen, Inc. v. Ariad Pharmaceuticals, Inc. (Fed. Cir. 2009)

By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry

By Andrew Williams -- On Monday, the Federal Circuit issued its decision in Amgen, Inc. v. Ariad Pharmaceuticals, Inc., dealing another blow to Ariad Pharmaceuticals and U.S. Patent No. 6,410,516, directed to certain aspects of the NF-?B transcription factor pathway. Previously, on April 3, the Federal Circuit held that four of the claims of the '516 patent were invalid because of a failure to satisfy the written description requirement. At that time, Patent Docs provided a detailed report of that case. In the present case, the Court affirmed a Delaware District Court's grant of Amgen's motion for summary judgment of...

Full post as published by Patent Docs on June 02, 2009 (boomark / email).